The availability of recombinant human chorionic gonadotrophin (r-hCG) has allowed us to measure its metabolic and renal clearance rates and to study the origin of the core fragment of hCG (hCG cf). Serum and urine samples were collected from six subjects, after an intravenous injection of 2 mg (equivalent to 44 000 IU Urinary hCG) r-hCG, and assayed for hCG and the beta subunit (hCG ). Urine from four of the subjects was also subjected to gel chromatography and assayed for hCG cf and hCG.r-hCG, administered as an intravenous dose, was distributed, initially in a volume of 3·4 0·7 l (mean ..) and then in 6·5 1·15 l at steady-state. The disappearance of r-hCG from serum was bi-exponential, with an initial half-life of 4·5 0·7 h and a terminal half-life of 29·0 4·6 h. The mean residence time was 28·6 3·6 h and the total systemic clearance rate of r-hCG was 226 18 ml/h. The renal clearance rate was 28·75 6·2 ml/h (mean .). hCG cf was detected in all urine samples collected at 6 h intervals. Over the 138 h period of urine collection, 12·9% (range 10·1-17·3% ) of r-hCG injected was recovered as the intact molecule and 1·7% (range 0·8-2·9%) was recovered as the hCG cf, in 4 subjects. The molar ratio of hCG cf to hCG in urine increased from 3·1 1·7%, on day 1, to 76 34·3% (mean ...) on day 5, after r-hCG infusion, suggesting that hCG cf is a metabolic product of the infused r-hCG.